Comparison of Transcriptomic Profiles of MiaPaCa-2 Pancreatic Cancer Cells Treated with Different Statins
Open accessThe DOI matches its Crossref record; 97 of the 98 references it cites were found in a registry or an index.
Abstract
Statins have been widely used for the treatment of hypercholesterolemia due to their ability to inhibit HMG-CoA reductase, the rate-limiting enzyme of de novo cholesterol synthesis, via the so-called mevalonate pathway. However, their inhibitory action also causes depletion of downstream intermediates of the pathway, resulting in the pleiotropic effects of statins, including the beneficial impact in the treatment of cancer. In our study, we compared the effect of all eight existing statins on the expression of genes, the products of which are implicated in cancer inhibition and suggested the molecular mechanisms of their action in epigenetic and posttranslational regulation, and in cell-cycle arrest, death, migration, or invasion of the cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This pharmacokinetic difference could explain why lipophilic statins have a stronger antiproliferative activity in preclinical systems”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Rimpelová et al., 2021
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“cerivastatin, pitavastatin, and simvastatin had the most significant transcriptomic impact on MIA PaCa-2 PDAC cell line, producing growth arrest and cytoskeletal remodeling, compared to lovastatin, fluvastatin, atorvastatin, pravastatin, and rosuvastatin”
From The antitumoral effect of statins in pancreatic ductal adenocarcinoma: a scoping review (2026) · cites this paper as Rimpelová et al., 2021
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“Data analysis was performed using the delta–delta Cq method [76] within the R statistical environment [77].”
MethodKEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077 · cited 1×
“visualized using the Pathview package [74] on the pathways provided by the KEGG database [75].”
MethodKEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038 · cited 1×
“Three housekeeping genes (RPS9, TBP, and GAPDH) were used as reference genes for RNA quantity normalization using the geNorm algorithm [78].”
MethodPrevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439 · cited 1×
“An increased incidence of breast cancer after statin administration was observed in one study [8], but another study did not confirm these findings [9].”
Result(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236 · cited 2×
“An increased incidence of breast cancer after statin administration was observed in one study [8], but another study did not confirm these findings [9].”
BackgroundResultSCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,645
Autophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608 · cited 1×
“Autophagy does not always result in programmed cell death, but it represents the important mechanism for catabolic production of ATP during nutrient stress, and also plays an important role in the turnover of proteins and organelles under nutrientreplete conditions [87].”
Background
Research works printed but not linked: 10
- (2021, February 09). NCBI, Available online: https://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=4998.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=983.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=994.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=6502.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=1870.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=8793.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=7138.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=3728.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=7430.
- (2021, February 09). NCBI, Available online: http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=1008.
Cited by
Statins and Bempedoic Acid: Different Actions of Cholesterol Inhibitors on Macrophage Activation
Linnenberger, R., Hoppstädter, J., Wrublewsky, S., Ampofo, E., & Kiemer, A. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212480 · Cited by 26
“Interestingly, cerivastatin has been shown to reduce the expression of genes involved in the MVA pathway to a higher degree than simvastatin [45], implying that this pathway may be especially vulnerable to cerivastatin-mediated interference.”
BackgroundCerivastatin Synergizes with Trametinib and Enhances Its Efficacy in the Therapy of Uveal Melanoma
Amaro, A. A., Gangemi, R. M. R., Emionite, L., Castagnola, P., Filaci, G., Jager, M. J., Tanda, E. T., Spagnolo, F., Mascherini, M., Pfeffer, U., et al. (2023) · Cancers · doi:10.3390/cancers15030886 · Cited by 17
“Upregulation of KRAS likely reflects the low levels of post-translationally modified KRAS protein due to the inhibition of the mevalonate pathway by cerivastatin [47,53,54].”
BackgroundInfluentialChoi, Y. S., Cho, H. J., & Jung, H. J. (2022) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2022.26.5.367 · Cited by 11
“Statins are potent competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase (HMGCR), which is a rate-limiting enzyme in the mevalonate pathway, approved by the Food and Drug Administration (FDA) as a lipid-lowering drug [9].”
BackgroundDuttenhefner, J. N., & Reindl, K. M. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.06.004 · Cited by 6
Marzoog, B. A., & Kopylov, F. Y. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm46903 · Cited by 6
Metadata
- Authors
- Rimpelová, S., Kolář, M., Strnad, H., Ruml, T., Vítek, L., & Gbelcová, H.
- Affiliations
- University of Chemistry and Technology, Prague (CZ)
- Czech Academy of Sciences (CZ)
- Institute of Medical Biochemistry and Laboratory Diagnostics, and 4th Department of Internal Medicine, 1st Faculty of Medicine, Charles University, 128 08 Prague, Czech Republic
- Comenius University Bratislava (SK)
- Corresponding author
- Rimpelová, Silvie
- Gbelcová, Helena
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2021-06-09
- Volume
- 26
- Issue
- 12
- Pages
- 3528
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC8226792
- OpenAlex
- W3171878125
- Cited by
- 8
- References
- 98
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 1
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Operational Programme Research, Development and Education (No. CZ.02.1.01/0.0/0.0/16_019/0000785)
- the Slovak Research and Development Agency (APVV-15-0217)
- the Czech Ministry of Health (RVO-VFN64165/2021)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- statins, pancreatic cancer, MIA PaCa-2 cells, gene expression profiling, HMG-CoA reductase inhibition, mevalonate pathway, pleiotropic effects of statins, gene expression, epigenetic regulation, post-translational regulation, cell cycle arrest, cell death, cell migration, cell invasion, anticancer effects
- MeSH terms
- Antineoplastic Agents, Cell Movement, Humans, Mevalonic Acid, Pancreatic Neoplasms, Cell Death, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Computational Biology, Epigenesis, Genetic, Cell Line, Tumor, Cell Proliferation, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of Transcriptomic Profiles of MiaPaCa-2 Pancreatic Cancer Cells Treated with Different Statins. https://app.cochat.ai/papers/10.3390/molecules26123528
- The paper
- Rimpelová, S., Kolář, M., Strnad, H., Ruml, T., Vítek, L., & Gbelcová, H. (2021). Comparison of Transcriptomic Profiles of MiaPaCa-2 Pancreatic Cancer Cells Treated with Different Statins. Molecules. https://doi.org/10.3390/molecules26123528
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.